Susquehanna Trust & Investment’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
BIT
Susquehanna Trust & Investment's BMY Position: Q2 2015 in Review
Susquehanna Trust & Investment reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q2 2015, selling an estimated $195K and leaving 16,693 shares worth $1.11M. The position accounts for 0.24% of the portfolio, ranked #65.
Susquehanna Trust & Investment first reported a position in BMY in Q2 2013 and has held it in 9 quarters since. The position peaked at $11.3M in Q3 2013. 1,448 funds tracked by Wall St. Rank hold BMY as of Q2 2015.
- Susquehanna Trust & Investment held 16,693 shares of Bristol-Myers Squibb worth $1.11M as of Q2 2015.
- Susquehanna Trust & Investment sold 2,952 Bristol-Myers Squibb shares in Q2 2015, an estimated $195K.
- Bristol-Myers Squibb made up 0.24% of Susquehanna Trust & Investment's portfolio in Q2 2015, its #65 holding.
- Susquehanna Trust & Investment first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 9 quarters since.
- Susquehanna Trust & Investment's Bristol-Myers Squibb position peaked at $11.3M in Q3 2013.
- 1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.
Based on Susquehanna Trust & Investment's 13F filing for Q2 2015, filed 24 Jul 2015.